Argus Research Maintains Buy on Albemarle, Lowers Price Target to $135
Argus Research analyst Alexandra Yates maintains Albemarle (NYSE:ALB) with a Buy and lowers the price target from $230 to $135.
Stocks · News reference
Michael Burry Warns Anthropic’s Valuation Could Buy 78 Profitable S&P 500 Companies: ‘Fun Game in Times Like These’
Michael Burry calls Anthropic's valuation a 'bubble,' noting it could buy 78 profitable S&P 500 companies like Domino's and Clorox.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
UBS Maintains Buy on Albemarle, Lowers Price Target to $150
UBS analyst Joshua Spector maintains Albemarle (NYSE:ALB) with a Buy and lowers the price target from $175 to $150.
Mizuho Maintains Neutral on Albemarle, Lowers Price Target to $130
Brown-Forman Looks Beyond Whiskey To Offset Jack Daniel’s Canada Problem
Brown-Forman faces pressure on Jack Daniel’s in Canada as New Mix and emerging markets become increasingly important growth drivers.
UBS Maintains Neutral on Brown-Forman, Raises Price Target to $30
Wells Fargo Maintains Equal-Weight on Clorox, Lowers Price Target to $85
Wells Fargo analyst Chris Carey maintains Clorox (NYSE:CLX) with a Equal-Weight and lowers the price target from $90 to $85.